Insufficient scRNA-seq data for expression of ASTL at single-cell level.
Insufficient scRNA-seq data for expression of ASTL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 56% | 10.98 | 101 / 180 | 56% | 2.01 | 240 / 430 |
spleen | 98% | 50.55 | 236 / 241 | 0% | 0 | 0 / 0 |
lung | 78% | 18.52 | 450 / 578 | 12% | 0.33 | 136 / 1155 |
bladder | 62% | 47.95 | 13 / 21 | 22% | 0.58 | 109 / 504 |
peripheral blood | 84% | 57.06 | 776 / 929 | 0% | 0 | 0 / 0 |
breast | 49% | 7.45 | 227 / 459 | 29% | 0.66 | 324 / 1118 |
skin | 72% | 35.82 | 1306 / 1809 | 4% | 0.06 | 18 / 472 |
prostate | 58% | 21.35 | 143 / 245 | 3% | 0.08 | 16 / 502 |
intestine | 49% | 11.05 | 476 / 966 | 12% | 0.31 | 64 / 527 |
stomach | 45% | 10.92 | 162 / 359 | 14% | 0.27 | 39 / 286 |
brain | 55% | 12.50 | 1465 / 2642 | 1% | 0.03 | 7 / 705 |
adipose | 48% | 7.53 | 576 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 36% | 5.13 | 527 / 1445 | 8% | 0.14 | 15 / 183 |
uterus | 30% | 3.29 | 51 / 170 | 14% | 0.41 | 66 / 459 |
kidney | 38% | 5.45 | 34 / 89 | 1% | 0.01 | 7 / 901 |
lymph node | 0% | 0 | 0 / 0 | 38% | 0.59 | 11 / 29 |
thymus | 23% | 3.28 | 147 / 653 | 14% | 0.31 | 84 / 605 |
blood vessel | 31% | 6.11 | 419 / 1335 | 0% | 0 | 0 / 0 |
heart | 21% | 2.18 | 177 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 18% | 0.26 | 8 / 45 |
muscle | 16% | 1.34 | 126 / 803 | 0% | 0 | 0 / 0 |
liver | 12% | 1.19 | 27 / 226 | 1% | 0.01 | 3 / 406 |
adrenal gland | 7% | 0.78 | 17 / 258 | 6% | 0.12 | 14 / 230 |
pancreas | 9% | 0.61 | 30 / 328 | 3% | 0.08 | 6 / 178 |
eye | 0% | 0 | 0 / 0 | 5% | 0.06 | 4 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009566 | Biological process | fertilization |
GO_0007155 | Biological process | cell adhesion |
GO_2000360 | Biological process | negative regulation of binding of sperm to zona pellucida |
GO_0006508 | Biological process | proteolysis |
GO_0060468 | Biological process | prevention of polyspermy |
GO_0010954 | Biological process | positive regulation of protein processing |
GO_0005886 | Cellular component | plasma membrane |
GO_0060473 | Cellular component | cortical granule |
GO_0005737 | Cellular component | cytoplasm |
GO_0070001 | Molecular function | aspartic-type peptidase activity |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0070002 | Molecular function | glutamic-type peptidase activity |
Gene name | ASTL |
Protein name | Metalloendopeptidase (EC 3.4.24.-) Astacin-like metalloendopeptidase (EC 3.4.-.-) (Oocyte astacin) (Ovastacin) (ZP2-proteinase) |
Synonyms | |
Description | FUNCTION: Oocyte-specific oolemmal receptor involved in sperm and egg adhesion and fertilization. Plays a role in the polyspermy inhibition. Probably acts as a protease for the post-fertilization cleavage of ZP2. Cleaves the sperm-binding ZP2 at the surface of the zona pellucida after fertilization and cortical granule exocytosis, rendering the zona pellucida unable to support further sperm binding. . |
Accessions | Q3B826 ENST00000342380.3 Q6HA08 |